SIGA Technologies reported a significant decrease in revenue for the third quarter of 2023, moving from $72.2 million in 2022 to $9.2 million. This resulted in a net loss of $0.4 million, a stark contrast to the $33.0 million net income reported in the same quarter of the previous year. The diluted loss per share was $0.01, compared to a diluted income per share of $0.45 in Q3 2022.
Total revenue decreased to $9.2 million compared to $72.2 million in the same quarter last year.
Net loss was $0.4 million, a significant change from the $33.0 million net income in Q3 2022.
Diluted loss per share was $0.01, compared to a diluted income per share of $0.45 in Q3 2022.
The company anticipates approximately $18 million in initial orders for oral TPOXX by EU countries under a new joint procurement framework contract.
SIGA Technologies anticipates full year 2023 pre-tax operating income of between $90 million and $100 million as they are targeting the delivery of approximately $113 million of oral TPOXX to the stockpile in the fourth quarter.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance